Systematic analysis of the p53‑related microRNAs in breast cancer revealing their essential roles in the cell cycle

Zhou,Enxiang; Hui,Na; Shu,Min; Wu,Baiping; Zhou,Jianlin

doi:10.3892/ol.2015.3751

Systematic analysis of the p53‑related microRNAs in breast cancer revealing their essential roles in the cell cycle

Authors:
- Enxiang Zhou
- Na Hui
- Min Shu
- Baiping Wu
- Jianlin Zhou
View Affiliations

Affiliations: Department of General Surgery, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, P.R. China, Key Laboratory of Protein Chemistry and Developmental Biology of the Ministry of Education, College of Life Science, Hunan Normal University, Changsha, Hunan 410081, P.R. China
Published online on: September 25, 2015 https://doi.org/10.3892/ol.2015.3751
Pages: 3488-3494
Copyright: © Zhou et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Numerous miRNAs have been found to be involved in the regulation of the p53 signaling pathway. Conversely, p53 regulates the transcription or processing of microRNAs (miRNAs). Given that complexities in the association between p53 and miRNAs exist, and due to the rapidly increasing amount of literature regarding the interactions between p53 and miRNAs, the present study systematically analyzed the associations between miRNAs and p53 in breast cancer using a literature‑based discovery approach, natural language processing. A total of 22 miRNAs were found to be associated with p53. Next, three popular online tools (PicTar, miRanda and TargetScan) were used to predict the targets of each miRNA, and certain targets were validated by experiments. Gene Ontology annotation and network analysis demonstrated that the majority of the targets of the p53‑related miRNAs were enriched in the cell cycle process. These results suggest that, in addition to regulating the transcription of cell cycle‑related genes, p53 also indirectly modulates the cell cycle via miRNAs.

View Figures

View References

1	Riley T, Sontag E, Chen P and Levine A: Transcriptional control of human p53-regulated genes. Nat Rev Mol Cell Biol. 9:402–412. 2008. View Article : Google Scholar : PubMed/NCBI
2	Levine AJ and Oren M: The first 30 years of p53: Growing ever more complex. Nat Rev Cancer. 9:749–758. 2009. View Article : Google Scholar : PubMed/NCBI
3	Petitjean A, Mathe E, Kato S, Ishioka C, Tavtigian SV, Hainaut P and Olivier M: Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: Lessons from recent developments in the IARC TP53 database. Hum Mutat. 28:622–629. 2007. View Article : Google Scholar : PubMed/NCBI
4	Gasco M, Shami S and Crook T: The p53 pathway in breast cancer. Breast Cancer Res. 4:70–76. 2002. View Article : Google Scholar : PubMed/NCBI
5	Lacroix M, Toillon RA and Leclercq G: p53 and breast cancer, an update. Endocr Relat Cancer. 13:293–325. 2006. View Article : Google Scholar : PubMed/NCBI
6	Krell J, Frampton AE, Colombo T, Gall TM, De Giorgio A, Harding V, Stebbing J and Castellano L: The p53 miRNA interactome and its potential role in the cancer clinic. Epigenomics. 5:417–428. 2013. View Article : Google Scholar : PubMed/NCBI
7	Wu N, Lin X, Zhao X, Zheng L, Xiao L, Liu J, Ge L and Cao S: MiR-125b acts as an oncogene in glioblastoma cells and inhibits cell apoptosis through p53 and p38MAPK-independent pathways. Br J Cancer. 109:2853–2863. 2013. View Article : Google Scholar : PubMed/NCBI
8	Liu Y, Xing R, Zhang X, Dong W, Zhang J, Yan Z, Li W, Cui J and Lu Y: miR-375 targets the p53 gene to regulate cellular response to ionizing radiation and etoposide in gastric cancer cells. DNA Repair (Amst). 12:741–750. 2013. View Article : Google Scholar : PubMed/NCBI
9	Ford NA, Dunlap SM, Wheatley KE and Hursting SD: Obesity, independent of p53 gene dosage, promotes mammary tumor progression and upregulates the p53 regulator microRNA-504. PLoS One. 8:e680892013. View Article : Google Scholar : PubMed/NCBI
10	Zhang C, Zhang J, Zhang A, Wang Y, Han L, You Y, Pu P and Kang C: PUMA is a novel target of miR-221/222 in human epithelial cancers. Int J Oncol. 37:1621–1626. 2010.PubMed/NCBI
11	Bisio A, De Sanctis V, Del Vescovo V, Denti MA, Jegga AG, Inga A and Ciribilli Y: Identification of new p53 target microRNAs by bioinformatics and functional analysis. BMC Cancer. 13:5522013. View Article : Google Scholar : PubMed/NCBI
12	Lin J, Huo R, Xiao L, Zhu X, Xie J, Sun S, He Y, Zhang J, Sun Y, Zhou Z, et al: A novel p53/microRNA-22/Cyr61 axis in synovial cells regulates inflammation in rheumatoid arthritis. Arthritis Rheumatol. 66:49–59. 2013. View Article : Google Scholar
13	Lezina L, Purmessur N, Antonov AV, Ivanova T, Karpova E, Krishan K, Ivan M, Aksenova V, Tentler D, Garabadgiu AV, et al: miR-16 and miR-26a target checkpoint kinases Wee1 and Chk1 in response to p53 activation by genotoxic stress. Cell Death Dis. 4:e9532013. View Article : Google Scholar : PubMed/NCBI
14	Léveillé N, Elkon R, Davalos V, Manoharan V, Hollingworth D, Oude Vrielink J, le Sage C, Melo CA, Horlings HM, Wesseling J, et al: Selective inhibition of microRNA accessibility by RBM38 is required for p53 activity. Nat Commun. 2:5132011. View Article : Google Scholar : PubMed/NCBI
15	Xu X, Fan Z, Kang L, Han J, Jiang C, Zheng X, Zhu Z, Jiao H, Lin J, Jiang K, et al: Hepatitis B virus X protein represses miRNA-148a to enhance tumorigenesis. J Clin Invest. 123:630–645. 2013.PubMed/NCBI
16	Kim T, Veronese A, Pichiorri F, Lee TJ, Jeon YJ, Volinia S, Pineau P, Marchio A, Palatini J, Suh SS, et al: p53 regulates epithelial-mesenchymal transition through microRNAs targeting ZEB1 and ZEB2. J Exp Med. 208:875–883. 2011. View Article : Google Scholar : PubMed/NCBI
17	Piovan C, Palmieri D, Di Leva G, et al: Oncosuppressive role of p53-induced miR-205 in triple negative breast cancer. Mol Oncol. 6:458–472. 2012. View Article : Google Scholar : PubMed/NCBI
18	Suzuki HI, Yamagata K, Sugimoto K, Iwamoto T, Kato S and Miyazono K: Modulation of microRNA processing by p53. Nature. 460:529–533. 2009. View Article : Google Scholar : PubMed/NCBI
19	Spizzo R, Nicoloso MS, Lupini L, Lu Y, Fogarty J, Rossi S, Zagatti B, Fabbri M, Veronese A, Liu X, et al: miR-145 participates with TP53 in a death-promoting regulatory loop and targets estrogen receptor-alpha in human breast cancer cells. Cell Death Differ. 17:246–254. 2010. View Article : Google Scholar : PubMed/NCBI
20	Chang J, Davis-Dusenbery BN, Kashima R, et al: Acetylation of p53 stimulates miRNA processing and determines cell survival following genotoxic stress. EMBO J. 32:3192–3205. 2013. View Article : Google Scholar : PubMed/NCBI
21	Gao W, Xu J, Liu L, Shen H, Zeng H and Shu Y: A systematic-analysis of predicted miR-21 targets identifies a signature for lung cancer. Biomed Pharmacother. 66:21–28. 2012. View Article : Google Scholar : PubMed/NCBI
22	Tang J, Zhang ZH and Liu GL: A systematic analysis of the predicted human La protein targets identified a hepatitis B virus infection signature. J Viral Hepat. 20:12–23. 2013. View Article : Google Scholar : PubMed/NCBI
23	Settles B: ABNER: An open source tool for automatically tagging genes, proteins and other entity names in text. Bioinformatics. 21:3191–3192. 2005. View Article : Google Scholar : PubMed/NCBI
24	Krek A, Grün D, Poy MN, Wolf R, Rosenberg L, Epstein EJ, MacMenamin P, da Piedade I, Gunsalus KC, et al: Combinatorial microRNA target predictions. Nat Genet. 37:495–500. 2005. View Article : Google Scholar : PubMed/NCBI
25	John B, Enright AJ, Aravin A, Tuschl T, Sander C and Marks DS: Human MicroRNA targets. PLoS Biol. 2:e3632004. View Article : Google Scholar : PubMed/NCBI
26	Lewis BP, Burge CB and Bartel DP: Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 120:15–20. 2005. View Article : Google Scholar : PubMed/NCBI
27	Salomonis N, Hanspers K, Zambon AC, Vranizan K, Lawlor SC, Dahlquist KD, Doniger SW, Stuart J, Conklin BR and Pico AR: GenMAPP 2: New features and resources for pathway analysis. BMC Bioinformatics. 8:2172007. View Article : Google Scholar : PubMed/NCBI
28	Pagel P, Kovac S, Oesterheld M, Brauner B, Dunger-Kaltenbach I, Frishman G, Montrone C, Mark P, Stümpflen V, Mewes HW, et al: The MIPS mammalian protein-protein interaction database. Bioinformatics. 21:832–834. 2005. View Article : Google Scholar : PubMed/NCBI
29	Pavlopoulos GA, Hooper SD, Sifrim A, Schneider R and Aerts J: Medusa: A tool for exploring and clustering biological networks. BMC Res Notes. 4:3842011. View Article : Google Scholar : PubMed/NCBI
30	Wu Y, Xiao Y, Ding X, Zhuo Y, Ren P, Zhou C and Zhou J: A miR-200b/200c/429-binding site polymorphism in the 3 untranslated region of the AP-2α gene is associated with cisplatin resistance. PLoS One. 6:e290432011. View Article : Google Scholar : PubMed/NCBI
31	Witkos TM, Koscianska E and Krzyzosiak WJ: Practical Aspects of microRNA Target Prediction. Curr Mol Med. 11:93–109. 2011. View Article : Google Scholar : PubMed/NCBI
32	Yang S, Banerjee S, Freitas A, Cui H, Xie N, Abraham E and Liu G: miR-21 regulates chronic hypoxia-induced pulmonary vascular remodeling. Am J Physiol Lung Cell Mol Physiol. 302:L521–L529. 2012. View Article : Google Scholar : PubMed/NCBI
33	Dellago H, Preschitz-Kammerhofer B, Terlecki-Zaniewicz L, Schreiner C, Fortschegger K, Chang MW, Hackl M, Monteforte R, Kühnel H, Schosserer M, et al: High levels of oncomiR-21 contribute to the senescence-induced growth arrest in normal human cells and its knock-down increases the replicative lifespan. Aging Cell. 12:446–458. 2013. View Article : Google Scholar : PubMed/NCBI
34	Marquez RT, Wendlandt E, Galle CS, Keck K and McCaffrey AP: MicroRNA-21 is upregulated during the proliferative phase of liver regeneration, targets Pellino-1, and inhibits NF-kappaB signaling. Am J Physiol Gastrointest Liver Physiol. 298:G535–G541. 2010. View Article : Google Scholar : PubMed/NCBI
35	Trohatou O, Zagoura D, Bitsika V, Pappa KI, Antsaklis A, Anagnou NP and Roubelakis MG: Sox2 suppression by miR-21 governs human mesenchymal stem cell properties. Stem Cells Transl Med. 3:54–68. 2014. View Article : Google Scholar : PubMed/NCBI
36	Chen B, Chen X, Wu X, Wang X, Wang Y, Lin TY, Kurata J, Wu J, Vonderfecht S, Sun G, et al: Disruption of microRNA-21 by TALEN leads to diminished cell transformation and increased expression of cell-environment interaction genes. Cancer Lett. 356:506–516. 2014. View Article : Google Scholar : PubMed/NCBI
37	Sandhir R, Gregory E and Berman NE: Differential response of miRNA-21 and its targets after traumatic brain injury in aging mice. Neurochem Int. 78:117–121. 2014. View Article : Google Scholar : PubMed/NCBI
38	Zhao J, Tang N, Wu K, Dai W, Ye C, Shi J, Zhang J, Ning B, Zeng X and Lin Y: MiR-21 simultaneously regulates ERK1 signaling in HSC activation and hepatocyte EMT in hepatic fibrosis. PLoS One. 9:e1080052014. View Article : Google Scholar : PubMed/NCBI
39	He X and Zhang J: Why do hubs tend to be essential in protein networks? PLoS Genet. 2:e882006. View Article : Google Scholar : PubMed/NCBI
40	Hsu PY, Deatherage DE, Rodriguez BA, Liyanarachchi S, Weng YI, Zuo T, Liu J, Cheng AS and Huang TH: Xenoestrogen-induced epigenetic repression of microRNA-9-3 in breast epithelial cells. Cancer Res. 69:5936–5945. 2009. View Article : Google Scholar : PubMed/NCBI
41	Frankel LB, Christoffersen NR, Jacobsen A, Lindow M, Krogh A and Lund AH: Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J Biol Chem. 283:1026–1033. 2008. View Article : Google Scholar : PubMed/NCBI
42	Li B, Wen G, Zhao Y, Tong J and Hei TK: The role of TGFBI in mesothelioma and breast cancer: Association with tumor suppression. BMC Cancer. 12:2392012. View Article : Google Scholar : PubMed/NCBI
43	Otsuka K and Ochiya T: Genetic networks lead and follow tumor development: microRNA regulation of cell cycle and apoptosis in the p53 pathways. Biomed Res Int. 2014:7497242014. View Article : Google Scholar : PubMed/NCBI
44	Rokavec M, Li H, Jiang L and Hermeking H: The p53/microRNA connection in gastrointestinal cancer. Clin Exp Gastroenterol. 7:395–413. 2014.PubMed/NCBI